3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Carcinoma
6
Lung Neoplasms
5
Nasopharyngeal Carcinoma
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Medulloblastoma
1
Locally Advanced Cervical Adenocarcinoma
1
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
Doxorubicin
3
Biopsy
3
palbociclib
2
abemaciclib
2
Radiotherapy
2
Radiation
2
talimogene laherparepvec
1
selinexor
1
ribociclib
1
peposertib
1
pazopanib
1
mirdametinib
1
liposomal doxorubicin
1
cemiplimab
1
X-Rays
1
Surgical Procedures, Operative
1
Proton Therapy
1
Neoadjuvant Therapy
1
Immunoglobulin G
1
Ifosfamide
1
Histamine H2 Antagonists
1
Gemcitabine
1
Famotidine
1
Everolimus
1
Docetaxel
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
30 days
×
Clear all
No trials found.